Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
04 November 2024 - 3:53PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT
OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 or 15d-16
UNDER
THE SECURITIES EXCHANGE ACT of 1934
For the Month of November 2024
333-206723
(Commission File Number)
P.V. NANO CELL LTD.
(Translation of registrant’s name into English)
8 Hamasger Street
Migdal Ha’Emek, 2310102, Israel
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual
reports under cover Form 20-F or Form 40-F.
Form 20-F ☒ Form
40-F ☐
P.V. Nano Cell Ltd. Announces Intention to Deregister its Ordinary
Shares
Midgal HaEmek, November 4, 2024 — P.V. Nano
Cell Ltd. (“PVN” or the “Company”), a conductive paste and ink manufacturing company focused on developing, manufacturing,
marketing and commercializing conductive pastes and inks for digital conductive printing applications, mainly screen printing and novel
printing technologies for the solar industry, announced today its intention to deregister its ordinary shares, par value NIS 0.01, and
suspend its reporting obligations under the Securities Exchange Act of 1934, as amended.
The Board of Directors’ decision to deregister
its ordinary shares and suspend reporting obligations was made after careful consideration of several factors, including reduced compliance
expenses associated with being a public reporting company. The Company’s Board of Directors believes that the deregistration, and
the related suspension of reporting obligations, will reduce the Company’s administrative expenses and enable the Company to focus
on operational matters that more directly impact shareholder value.
The Company anticipates that the termination of
registration will become effective within 90 days following the filing of Form 15 with the U.S. Securities and Exchange Commission (“SEC”).
Upon filing Form 15, the Company’s obligation to file certain reports, including Form 20-F and Form 6-K, with the SEC, will immediately
be suspended.
The Company reserves the right to delay or withdraw
the filings for any reason prior to effectiveness.
This report contains “forward-looking”
statements within the meaning of Section 27A of the U.S. Securities Act of 1933, as amended, and Section 21E of the U.S. Securities Exchange
Act of 1934, as amended. Such statements express the current intent, belief or expectations of the Company and its management. Any such
forward-looking statements involve a number of risks, uncertainties and assumptions that could materially affect actual results, performance
or achievements, including the risks and uncertainties identified in the Company’s Annual Report on Form 20-F for the year ended
December 31, 2023, filed with the U.S. Securities and Exchange Commission.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized.
Date: November 4, 2024 |
P.V. NANO CELL LTD. |
|
|
|
|
By: |
/s/ Avi
Magid |
|
|
Name: |
Avi Magid |
|
|
Title: |
Chief Executive Officer |
2
PV Nano Cell (PK) (USOTC:PVNNF)
Historical Stock Chart
Von Nov 2024 bis Dez 2024
PV Nano Cell (PK) (USOTC:PVNNF)
Historical Stock Chart
Von Dez 2023 bis Dez 2024